ReproCell Inc
TSE:4978
ReproCell Inc
Capital Expenditures
ReproCell Inc
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ReproCell Inc
TSE:4978
|
Capital Expenditures
-¥115.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Capital Expenditures
-¥1.9B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-25%
|
|
PeptiDream Inc
TSE:4587
|
Capital Expenditures
-¥1.4B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Capital Expenditures
-¥12.9B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-8%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Capital Expenditures
-¥273.2m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-23%
|
S
|
StemRIM Inc
TSE:4599
|
Capital Expenditures
-¥350k
|
CAGR 3-Years
87%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ReproCell Inc's Capital Expenditures?
Capital Expenditures
-115.4m
JPY
Based on the financial report for Dec 31, 2023, ReproCell Inc's Capital Expenditures amounts to -115.4m JPY.
What is ReproCell Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-11%
Over the last year, the Capital Expenditures growth was -33%. The average annual Capital Expenditures growth rates for ReproCell Inc have been -1% over the past three years , -11% over the past five years .